Clinical Trials Logo

Clinical Trial Summary

The study was to determine if the drug worked to relieve nasal congestion experienced by people with seasonal allergies.


Clinical Trial Description

Subjects who met the inclusion/exclusion criteria were enrolled into the placebo run-in phase of the study on Day -7 (prerandomization, Visit 1). Baseline symptom scores were established during this run-in phase.

Subjects with moderate nasal congestion who took at least 80% of their study medication during the run-in phase were eligible for enrollment in the two-week double-blind phase of the study and were randomized on Day 1 (randomization, Visit 2). They were treated for two weeks with their assigned medication. The severity of signs/symptoms were evaluated by the subjects every morning and night and by the investigator at each visit on Day 7 and Day 14.

In addition, the subject and investigator provided a global evaluation of response to treatment on Day 7 and Day 14. Safety was evaluated by adverse events reported during the study, vital signs, and the incidence of somnolence. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00648973
Study type Interventional
Source Johnson & Johnson Consumer and Personal Products Worldwide
Contact
Status Completed
Phase Phase 4
Start date November 2006
Completion date May 2007

See also
  Status Clinical Trial Phase
Completed NCT00665977 - Effect of Heated Humidity With Thermosmartâ„¢ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure Phase 3
Completed NCT05843071 - PMCF Study to Evaluate Performance and Safety of "NASAL SPRAYS " Used to Relieve Nasal Congestion and Dryness N/A
Completed NCT00957996 - Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Phase 3
Completed NCT00829634 - Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation N/A
Completed NCT00662337 - Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride Phase 1
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Recruiting NCT05244148 - Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects N/A
Completed NCT05159271 - Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults N/A
Completed NCT02113449 - Market Potential of Carbon Dioxide Nasal Spray Phase 2
Terminated NCT00958776 - A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza Phase 3
Completed NCT03399721 - Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis N/A
Completed NCT01354418 - Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED) Phase 1
Completed NCT04797936 - BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 Phase 4
Completed NCT03906968 - The Safety and Efficacy of a SinuSonic Intervention N/A
Completed NCT02100605 - Study on Hypertonic Saline Nasal Spray N/A
Recruiting NCT06323304 - Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis N/A
Withdrawn NCT04790487 - Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis Phase 2/Phase 3
Completed NCT01448057 - Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu Phase 3
Completed NCT01129765 - Home Usability of a Nasal Lavage System in Children N/A
Completed NCT04910139 - A User Study of the Soniflow System for Nasal Congestion Relief N/A